Ribosomal dna abundance in the patient’s genome as a feasible marker in differential diagnostics of autism and childhood-onset schizophrenia

HIGHLIGHTS

• who: Elizaveta S. Ershova et al. from the Research Centre for Medical Genetics, Department of Molecular Biology, Moscow, Russia Department of Medical Genetics, IM. Sechenov First Moscow State Medical University (Sechenov University) have published the paper: Ribosomal DNA Abundance in the Patientu2019s Genome as a Feasible Marker in Differential Diagnostics of Autism and Childhood-Onset Schizophrenia, in the Journal: (JOURNAL) of 29/08/2022
• what: The aim of this study is comparative analysis of rDNA copy numbers in blood cell genomes in three groups of children: schizophrenia patients, autism patients, and healthy controls. x FOR . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.